GLP-1, or glucagon-like peptide-1, is a hormone produced in our gut in response to food intake
In this patient group, the efficacy of LDL-C reduction using PCSK9 inhibitors, i.e., evolocumab [265] and alirocumab [288], is well documented
Our formulations are designed with high-quality, science-backed ingredients that support overall wellness
Filing the lawsuit: An attorney can aid you in filing the lawsuit in the correct jurisdiction and within the statute of limitations
The drug slows gastric emptying, leading to increased feelings of fullness and reduced appetite
Muscle aches have been reported in 5% or fewer of patients and usually resolve without intervention